Leveraging Cisplatin-Derived Prodrugs as Helper Lipids in LNPs to Boost the Efficacy of Cancer Chemoimmunotherapy
ACS Nano · 13.01.2026 · 20 (1) · 1448-1461
DOI: 10.1021/acsnano.5c18243 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 22.12.2025. Verfasst von Xuanbo Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan 523059, China. Hauptthemen laut MEDLINE: Prodrugs, Cisplatin, Lipids, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Medical Research Council, Ministry of Education - Singapore, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan 523059, China.
- School of Pharmacy, Hainan Medical University, Haikou, Hainan 571199 China.
- Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning 530000 China.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore.
- Medical Laboratory of the Third Affiliated Hospital of Shenzhen University, Shenzhen 518112 China.
- Cancer Center, Dongguan Institute of Clinical Cancer Research, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan 523059, China.
ORCID-Profile: Dixian Luo, Xiaoyuan Chen, Zhiqiang Yu
Förderung
- National Medical Research Council
- Ministry of Education - Singapore
- China Postdoctoral Science Foundation
- National Research Foundation Singapore
- National University of Singapore
- National Natural Science Foundation of China
- Shenzhen University
Zitieren
APA
Zhang, X., Ning, S., Fang, F., Zhou, C., Yang, Z., Cao, L., Wang, K., Feng, Z., Li, B., Luo, D., Xu, X., Liu, Z., Chen, X., & Yu, Z. (2026). Leveraging Cisplatin-Derived Prodrugs as Helper Lipids in LNPs to Boost the Efficacy of Cancer Chemoimmunotherapy. ACS Nano, 20(1), 1448-1461. https://doi.org/10.1021/acsnano.5c18243
Vancouver
Zhang X, Ning S, Fang F, Zhou C, Yang Z, Cao L, et al. Leveraging Cisplatin-Derived Prodrugs as Helper Lipids in LNPs to Boost the Efficacy of Cancer Chemoimmunotherapy. ACS Nano. 2026;20(1):1448-1461. doi:10.1021/acsnano.5c18243
BibTeX
@article{Zhang2026,
author = {Zhang, Xuanbo and Ning, Shipeng and Fang, Feng and Zhou, Cao and Yang, Zifan and Cao, Liping and Wang, Kaiyuan and Feng, Zunyong and Li, Bingyu and Luo, Dixian and Xu, Xiao and Liu, Zhigang and Chen, Xiaoyuan and Yu, Zhiqiang},
title = {Leveraging Cisplatin-Derived Prodrugs as Helper Lipids in LNPs to Boost the Efficacy of Cancer Chemoimmunotherapy},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {1},
pages = {1448--1461},
doi = {10.1021/acsnano.5c18243}
}
EUVIMED